Bicocca Open Archive

Logo unimib boa
CAIROLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.127
AS - Asia 3.543
NA - Nord America 2.727
SA - Sud America 250
AF - Africa 39
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.700
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.667
SG - Singapore 1.461
HK - Hong Kong 1.387
RU - Federazione Russa 1.377
IT - Italia 1.002
IE - Irlanda 896
CN - Cina 302
DE - Germania 221
BR - Brasile 220
ID - Indonesia 187
SE - Svezia 115
GB - Regno Unito 107
NL - Olanda 70
IN - India 68
AT - Austria 67
FI - Finlandia 64
ES - Italia 39
UA - Ucraina 39
FR - Francia 30
CA - Canada 28
MX - Messico 24
JP - Giappone 22
CH - Svizzera 18
TR - Turchia 17
AU - Australia 12
PH - Filippine 12
VN - Vietnam 12
BE - Belgio 11
MA - Marocco 10
ZA - Sudafrica 10
DK - Danimarca 9
CO - Colombia 8
CZ - Repubblica Ceca 8
HR - Croazia 8
SA - Arabia Saudita 8
CL - Cile 7
GR - Grecia 7
HU - Ungheria 7
KR - Corea 7
TN - Tunisia 7
IL - Israele 6
IR - Iran 6
NP - Nepal 6
PL - Polonia 6
TW - Taiwan 6
AR - Argentina 5
BD - Bangladesh 5
EG - Egitto 5
PK - Pakistan 5
UZ - Uzbekistan 5
VE - Venezuela 5
AZ - Azerbaigian 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
IQ - Iraq 3
JO - Giordania 3
NO - Norvegia 3
AM - Armenia 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GE - Georgia 2
KE - Kenya 2
LT - Lituania 2
NI - Nicaragua 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
UY - Uruguay 1
Totale 10.700
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.381
Singapore 902
Dublin 845
Santa Clara 402
New York 391
Milan 272
Ashburn 195
Jakarta 171
Ann Arbor 124
Beijing 117
Turin 88
Nuremberg 84
Frankfurt am Main 77
Moscow 76
Seattle 59
Shanghai 51
Fairfield 46
Rome 46
Helsinki 42
Chandler 41
Desio 41
São Paulo 41
Boardman 34
London 31
Vienna 30
Los Angeles 27
Washington 25
Amsterdam 24
Houston 22
Jacksonville 19
Princeton 18
Wilmington 18
Kilburn 17
Madrid 17
Assago 16
Dearborn 16
Lappeenranta 16
Bologna 14
Cinisello Balsamo 14
Cambridge 13
Hyderabad 13
Naples 13
Phoenix 13
Woodbridge 13
Mumbai 12
Guadalajara 11
Nanjing 10
Altamura 9
Aurora 9
Lawrence 9
Manila 9
Paris 9
San Diego 9
Brescia 8
Brussels 8
Carate Brianza 8
Chiswick 8
Genoa 8
Verona 8
Debrecen 7
Delhi 7
Florence 7
Istanbul 7
Orbassano 7
Rio de Janeiro 7
Villongo 7
Zagreb 7
Changsha 6
Council Bluffs 6
Kolkata 6
Montreal 6
New Delhi 6
Prague 6
Santa Monica 6
Tel Aviv 6
Toronto 6
Brugherio 5
Chengdu 5
Corsico 5
Dallas 5
Guangzhou 5
Melbourne 5
Melzo 5
Palermo 5
Rocca Canavese 5
San Jose 5
Shijiazhuang 5
Taiyuan 5
Tunis 5
Veniano 5
Baku 4
Bari 4
Belo Horizonte 4
Bengaluru 4
Biratnagar 4
Caracas 4
Catania 4
Chicago 4
Cologno Monzese 4
Como 4
Totale 6.270
Salva come PNG Salva come JPEG
Nome #
Assessing eligibility for treatment in acute myeloid leukemia in 2023 307
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 221
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 171
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia 162
The role of quantitative polymerase chain reaction in the management of follicular lymphoma patients 148
Impact of serial echocardiography in the management of primary cardiac lymphoma 140
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients 116
KIT activating mutations: Incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication 114
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review 96
Optimal Duration of CPX-351 Treatment and Best Timing for Consolidation with Allogeneic Stem Cell Transplantation: Evidence from a Large Real-World Italian Study 78
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 78
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities 73
Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia 72
Use of Sorafenib in FLT3-Mutant Myeloid Sarcoma: A Case Report 72
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 72
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 69
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 67
Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study 66
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial 64
Lymphoma’s last therapeutic option: Freeze it! 59
Cordycepin (3′dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC 58
IN ADULT ACUTE MYELOID LEUKEMIA (AML) PERIPHERAL BLOOD MEASURABLE RESIDUAL DISEASE (MRD) BY FLOW CYTOMETRY (FC) IS FEASIBLE AND IS PROGNOSTICALLY RELEVANT 57
Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 57
MIS-A: Beware of non-lymphoma 56
Cost-effectiveness analysis of gemtuzumab ozogamicin for the treatment of de novo CD33-positive Acute Myeloid Leukaemia (AML) in Italy 55
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? 55
"Efficient Strategies for the Reuse of Surgical and FFP2/ KN95 Face Masks during the COVID-19 Pandemic: Home-Made and Ecological Choices for the Community" 53
Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 52
How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia 52
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study 52
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 51
A novel start-loss mutation of the SH2B3 gene in a family with myeloproliferative neoplasms 51
Myeloma’s multiple morphologies 50
Exploring the administrative burden faced by hematologists: a comprehensive study in Italy 50
Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization 49
Arg expression studied in normal human leukocytes and in leukemic cells by RT-PCR 48
A phase I/II study of NMS-03592088, a FLT3, KIT and CSF1R inhibitor, in patients with relapsed or refractory AML or CMML 47
Real World Outcome of Unfit Patients with Acute Myeloid Leukemia Treated with the Combination Venetoclax Plus Hypomethylating Agents in the Gimema AML2320 Observational Trial 47
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda 46
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 45
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 45
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: Results of an Italian multicenter study 45
c-kit activating mutations and mast cell proliferation in human leukemia [4] 45
Dual antiviral therapy in haematological patients with protracted SARS-CoV-2 infection 45
VENETOCLAX IN MULTI-RELAPSED MANTLE CELL LYMPHOMA PATIENTS: A REAL-LIFE MULTICENTRIC EXPERIENCE 44
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy? 44
Fungal infections in hematologic neoplasms: Autopsy findings 44
Fasting and Diet: Overview in Chronic Lymphocytic Leukemia 43
A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting 43
Progressive Down Regulation of JAK-STAT, Cell Cycle, and ABC Transporter Genes in CD34+/Lin- Cells of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients at Diagnosis Vs. 12 Months of Nilotinib Treatment Vs. Healthy Subjects 43
Intrahospital COVID-19 infection outbreak management: Keep calm and carry on 43
Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT 42
Multidimensional Results and Reflections on CAR-T: The Italian Evidence 42
Detection by polymerase chain reaction of BCR/ ABL transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation 41
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol 41
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 41
ACUTE PROMYELOCYTIC LEUKEMIA - COMPLETE REMISSION AND BONE-MARROW TRANSPLANTATION FOLLOW-UP MONITORED BY POLYMERASE CHAIN-REACTION 41
LABNET AML: AN EFFICIENT NETWORK THAT CONNECTS HEMATOLOGY CENTERS AND LABORATORIES FOR A HIGH-LEVEL DIAGNOSTIC/PROGNOSTIC WORKUP OF AML 41
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis 40
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913 40
Use of Plerixafor in Poor Mobilizer Patients with Myeloma and Lymphoma: Clonogenic Capacity and Engraftment Data 40
C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index 40
Prognostic significance of CD33, CD34 and CD117 expression on bone marrow blasts of patients with Myelodysplastic syndromes 40
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis 40
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy) 40
CLINICAL RELEVANCE OF RECURRENT ALLELE-SPECIFIC RECOMBINATION EXPRESSING THE WNT10BIVS1 ALLELE VARIANT IN ACUTE MYELOID LEUKEMIA 40
Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial (Experimental Hematology & Oncology, (2021), 10, 1, (14), 10.1186/s40164-021-00210-9) 40
Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles 39
PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation 39
Hypoplasia of the Spleen: Rare and Puzzling 39
IDENTIFICAZIONE DI MIRNA E GENI TARGET NELL’ANALISI TRASCRITTOMICA DELLE CELLULE CD34+/LIN- DI PAZIENTI CON LEUCEMIA MIELOIDE CRONICA IN FASE CRONICA DOPO 12 MESI DI TERAPIA CON NILOTINIB 39
A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice 39
Treatment of elderly patients with acute promyelocytic leukemia: A real life experience of the “rete ematologica lombarda” 39
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma 38
Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial 38
RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML1310 TRIAL OF THE GIMEMA GROUP 37
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS 37
Prospective clinical study on extracorporeal photopheresis (ECP) as prophylaxis for chronic Graft Versus Host Disease (cGVHD) prophylaxis: an interim analysis 37
Plasma cell-directed therapy and anti-HLA antibody production: A successful combination? 37
Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience 37
Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS) 37
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19 37
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL) 37
Detection of c-KIT antigen (CD117) and c-kit mRNA in acute leukemia 37
New Insights from CAR-T: An Economic and Organizational Perspective 37
High dose etoposide and cyclophosphamide (HD-VP/CTX) as salvage treatment for all patients 37
Prognostic impact of C-KIT mutations in Core Binding Factor-Leukemia 36
PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS 36
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia 36
Gastrointestinal Kaposi's Sarcoma in a Woman with Selective IgA Deficiency and prior Immunosuppressive therapy for Idiopathic Thrombocitopenioc Purpura 36
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H 36
Prevalence and prognostic impact of KIT mutations in acute myeloid leukaemia with INV(16) 35
Identification of genes differently expressed between bone marrow CD34+/LIN-cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs 12 months of first-line nilotinib treatment 35
Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era 35
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment 35
Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations. A report of three cases 35
CD117 expression in acute leukemia 35
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 34
Targeted Therapy in FLT3-ITD Positive Myeloid Sarcoma: Proof of Principle 34
The ERK1/2 Regulator WNK2 Shows Novel Alternative Splicing Aberrations That Support Tumor Growth in MYD88 Mutated Waldenstrom's Macroglobulinemia 34
Totale 5.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.164
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 4 4 3
2020/2021141 3 3 40 14 15 11 12 12 14 6 3 8
2021/2022121 6 3 15 7 11 10 2 14 7 8 12 26
2022/20231.417 27 57 11 13 9 26 0 151 58 921 64 80
2023/20243.794 57 115 139 106 515 840 653 200 657 104 76 332
2024/20256.010 545 1.184 457 439 783 295 687 221 844 555 0 0
Totale 11.693